Around 300 Endocrinology specialists have met in Madrid in the framework of the meetingChanges in your lifestyle that condition your day to day.
2 Lilly Logoade more of the guidelines in food and exercise, these patients “must adjust the food schedules, adapt their work or daily activity and, on some occasions, use injectable treatments that require strict dose adjustments, and sometimes complex,Based on glycemia automation, ”as indicated in the encounter.
In this context, new therapeutic options have emerged that allow facilitating the adaptation of patients to an injectable treatment and improving their feeling of independence: “The recent launch of Dreamaglutida in Spain allows us to have an extremely easy to use alternative, with a largeEffectiveness and security, and a weekly administration that brings great freedom to patients to organize their lives beyond the disease, ”said the endocrinologist of the Endocrinology Service of the Clinic Hospital of Barcelona, Ignacio Conget.
new weekly antidiabetic treatment
Specifically, “DreamaglutidOffer a reduction of glucosylated hemoglobin significant and comparable to the maximum dose of liraglutida (1.8 mg), which requires a daily injection ”, as reported during the meeting.
"Having Dreamaglutida helps the patient to achieve their control objectives by being effective without specifying dosage or demanding the observation of a strict schedule," said the head of the Endocrinology and Nutrition Service of the Quirón University Hospital in Madrid, Esteban Jódar.“As for schedules, it can be administered at any time during the week, regardless of meals, and also has additional benefits since it does not cause hypoglycemia per se and also helps something as difficult as controlling the weight, also having effectsbeneficial in that sense, ”added Jódar.
Finally, in the words of the endocrinologist of the Endocrinology Service of the Son Espases University of Palma de Mallorca, Santiago Tofé: “The complexity of many of the antidiabetic treatments is a very important stumblingInjectable therapy.Faced with this, the Weekly Administration of Dreamaglutida, which is accompanied by a pen designed for greater comfort of the patient, also allows during its use, does not have to see or manipulate the needle. ”